NCT02715037

Brief Summary

Prospective, observational study of the microbiology of patients referred to a tertiary care center with severe acute tonsillitis, peritonsillar cellulitis, or infectious mononucleosis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
350

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 14, 2016

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 22, 2016

Completed
2 months until next milestone

Study Start

First participant enrolled

June 1, 2016

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2019

Completed
2.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

March 22, 2016

Status Verified

March 1, 2016

Enrollment Period

2.9 years

First QC Date

March 14, 2016

Last Update Submit

March 21, 2016

Conditions

Keywords

fusobacterium necrophorumacute tonsillitisperitonsillar cellulitisinfectious mononucleosismicrobiologyantibody development

Outcome Measures

Primary Outcomes (1)

  • Prevalence of Fusobacterium necrophorum in throat swab cultures

    At acute consultation (day 0)

Secondary Outcomes (4)

  • Number of participants with recurrent throat infections (questionnaire)

    Six months after acute consultation

  • Number of participants without eradication of throat pathogens (throat cultures)

    14-28 days after acute consultation

  • Number of participants with complications of severe acute tonsillitis, peritonsillar cellulitis, and infectious mononucleosis

    14-28 days after acute consultation

  • Prevalence of anti-Fusobacterium necrophorum antibody Development (two-fold or higher increase in antibody level) (blood samples)

    In acute and convalescent sera (day 0 and 14-28)

Study Arms (4)

Acute tonsillitis

Patients referred to the tertiary care center with severe acute tonsillitis but without peritonsillar cellulitis, infectious mononucleosis, or abscess formation.

Other: Throat swabbing

Peritonsillar cellulitis

Patients referred to the tertiary care center with severe acute tonsillitis and peritonsillar cellulitis but without abscess formation.

Other: Throat swabbing

Infectious mononucleosis

Patients referred to the tertiary care center with acute tonsillitis and biochemical or serological signs of infectious mononucleosis but without abscess formation.

Other: Throat swabbing

Controls

Patients treated for conditions not related to the throat and without signs or symptoms of recent throat disease.

Other: Throat swabbing

Interventions

Also known as: Blood sample
Acute tonsillitisControlsInfectious mononucleosisPeritonsillar cellulitis

Eligibility Criteria

Age15 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

100 patients with severe acute tonsillitis 100 patients with peritonsillar cellulitis 50 patients with infectious mononucleosis

You may qualify if:

  • Patients referred to our tertiary care center with acute tonsillitis with or without signs of peritonsillar cellulitis and with or without infectious mononucleosis.
  • Center Score 3 or 4.

You may not qualify if:

  • Abscess formation.
  • Previous tonsillectomy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aarhus University Hospital

Aarhus, Aarhus, 8000, Denmark

Location

Related Publications (4)

  • Klug TE, Henriksen JJ, Rusan M, Fuursted K, Krogfelt KA, Ovesen T, Struve C. Antibody development to Fusobacterium necrophorum in patients with peritonsillar abscess. Eur J Clin Microbiol Infect Dis. 2014 Oct;33(10):1733-9. doi: 10.1007/s10096-014-2130-y. Epub 2014 May 9.

    PMID: 24810966BACKGROUND
  • Klug TE. Incidence and microbiology of peritonsillar abscess: the influence of season, age, and gender. Eur J Clin Microbiol Infect Dis. 2014 Jul;33(7):1163-7. doi: 10.1007/s10096-014-2052-8. Epub 2014 Jan 29.

    PMID: 24474247BACKGROUND
  • Klug TE, Henriksen JJ, Fuursted K, Ovesen T. Significant pathogens in peritonsillar abscesses. Eur J Clin Microbiol Infect Dis. 2011 May;30(5):619-27. doi: 10.1007/s10096-010-1130-9. Epub 2010 Dec 22.

    PMID: 21181222BACKGROUND
  • Ehlers Klug T, Rusan M, Fuursted K, Ovesen T. Fusobacterium necrophorum: most prevalent pathogen in peritonsillar abscess in Denmark. Clin Infect Dis. 2009 Nov 15;49(10):1467-72. doi: 10.1086/644616.

    PMID: 19842975BACKGROUND

Biospecimen

Retention: SAMPLES WITH DNA

Throat swabs Blood samples

MeSH Terms

Conditions

Infectious Mononucleosis

Interventions

Blood Specimen Collection

Condition Hierarchy (Ancestors)

Epstein-Barr Virus InfectionsHerpesviridae InfectionsDNA Virus InfectionsVirus DiseasesInfectionsLeukocyte DisordersHematologic DiseasesHemic and Lymphatic DiseasesLymphoproliferative DisordersLymphatic DiseasesImmunoproliferative DisordersImmune System Diseases

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Consultant, associate professor

Study Record Dates

First Submitted

March 14, 2016

First Posted

March 22, 2016

Study Start

June 1, 2016

Primary Completion

May 1, 2019

Study Completion

December 1, 2021

Last Updated

March 22, 2016

Record last verified: 2016-03

Data Sharing

IPD Sharing
Will not share

Locations